SCHEMBL19508917

SCHEMBL19508917

ICOCc1ccc2ccccc2c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.50
CYP2A6 P11509 1/20 0.50
RAB9A P51151 1/20 0.47
SLC6A2 P23975 3/20 0.46
SLC6A4 P31645 3/20 0.46
SLC6A3 Q01959 3/20 0.46
HTR2A P28223 2/20 0.46
HTR2C P28335 2/20 0.46
HTR2B P41595 2/20 0.46
HTR7 P34969 1/20 0.46
HTR3A P46098 1/20 0.46
HTR4 Q13639 1/20 0.46
TACR1 P25103 2/20 0.44
ALOX5 P09917 2/20 0.44
KCNH2 Q12809 2/20 0.44
CNR1 P21554 2/20 0.43
CNR2 P34972 2/20 0.43
SLC1A3 P43003 1/20 0.43
SLC1A2 P43004 1/20 0.43
SLC1A1 P43005 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL433146 0.87 CYP1A2 (0.58) CYP1A2CYP2A6RAB9ASLC6A2SLC6A4
SCHEMBL28367677 0.84 RAB9A (0.51) CYP1A2CYP2A6RAB9ASLC6A2SLC6A4
SCHEMBL7648436 0.82 TSHR (0.62) CYP1A2CYP2A6RAB9ASLC6A2SLC6A4
SCHEMBL16174483 0.82 CYP1A2 (0.52) CYP1A2CYP2A6RAB9ASLC6A2SLC6A4
SCHEMBL19249093 0.80 CYP1A2 (0.50) CYP1A2CYP2A6RAB9ASLC6A2SLC6A4
SCHEMBL19249099 0.80 CYP1A2 (0.50) CYP1A2CYP2A6RAB9ASLC6A2SLC6A4
SCHEMBL2108042 0.80 CYP1A2 (0.50) CYP1A2CYP2A6RAB9ASLC6A2SLC6A4
SCHEMBL19249290 0.80 CYP1A2 (0.50) CYP1A2CYP2A6RAB9ASLC6A2SLC6A4
SCHEMBL13977956 0.80 CYP1A2 (0.50) CYP1A2CYP2A6RAB9ASLC6A2SLC6A4
SCHEMBL4177442 0.80 CYP1A2 (0.61) CYP1A2CYP2A6RAB9ASLC6A2SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170305809-A1 AGENT FOR INTRODUCING PROTECTING GROUP FOR HYDROXY GROUP AND/OR MERCAPTO GROUP KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) 2017-10-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170305809-A1 AGENT FOR INTRODUCING PROTECTING GROUP FOR HYDROXY GROUP AND/OR MERCAPTO GROUP GRHPR, AOX1, MSRB3 CYP1A2 262/4885CYP2A6 214/4885RAB9A 4009/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.